Pharma & Bio
Lifestyle
WiseBirds Leads the Way in Direct Sales of K-Bio Products to North America... ‘Support for a Second Zimpentra’
#WiseBirds, a comprehensive digital marketing firm, has stepped in as a “rescue pitcher” for South Korean pharmaceutical, biotech, and medical device (hereinafter “bio”) companies looking to export to…
Technology
Orum Therapeutics Establishes a Base in Shanghai… Sets Out to Identify ADC Technologies in China
#Orum Therapeutics, a developer of targeted protein degradation (TPD)-based antibody-degradator conjugates (DACs), is establishing a base of operations in Shanghai, China.On the surface, this move is …
Lifestyle
Selbion: Will It Become the Creator of ‘Korea’s 44th New Drug’?... Second Half to Be a Turning Point for Conditional Approval
Market attention is focused on whether #Cellion, regarded as a pioneer in the domestic radiopharmaceutical (RPT) market, will make history with a new domestically developed drug. Recently, #Curocell’s…
Technology
'JLK's Japanese Subsidiary Begins Full Operations'... Global Earnings Set for Quantum Leap
#JLK, South Korea’s first publicly listed medical artificial intelligence (AI) company, has entered the monetization phase in the Japanese market.Having obtained a direct sales license through its Jap…
Technology
Kim Pil-han, CEO of iBeam Technology: "Successfully Supplied Products to Big Pharma Company Sanofi... Double Growth Expected This Year"
“We expect this year’s revenue to more than double compared to last year (approximately 4.2 billion won). Seasonally, the second half of the year always accounts for 60–70% of total revenue, but it ap…
Lifestyle
HLB Shares Surge on Hopes of FDA Review...Seers Predict a Rznomics Rally [K-Bio Pulse]
On June 16, South Korean pharmaceutical and biotechnology stocks were driven largely by company-specific catalysts, including regulatory expectations, business momentum, and shareholder-friendly initi…
Lifestyle
HLB Soars on Possibility of Written Review for New Liver Cancer Drug... Ciers and Algenomics Also Rise on Positive News [Bio Spotlight]
On the 16th, the pharmaceutical and biotech stock market saw a mixed performance among individual stocks as business momentum and shareholder returns intersected. Shares of HLB Group affiliates surged…
Lifestyle
Halozime Finally Abandons UK Patent… Good News for Alteogen? [Exclusive to Edaily]
#It has been confirmed that Altogen’s partner, Merck (MSD), has secured a complete victory in a lawsuit filed in the UK regarding Halozime’s European patent. With Halozime voluntarily revoking its UK …
Technology
SK Bioscience Forecasts Earnings Rebound, Led by Its Two Mainstays: CDMO and Next-Generation Pneumonia Vaccine
#SK Bioscience is aiming for a turnaround in its earnings by focusing on its contract development and manufacturing (CDMO) business and its 21-valent pneumococcal vaccine candidate, “GBP410.” As the c…
Technology
Genome & Company’s ‘Business Transformation’: ADC Trio as Future Growth Drivers
#Genome & Company is transforming from a microbiome company into a firm specializing in antibody-drug conjugates (ADCs). As recently as two years ago, the company was strongly associated with the deve…